Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Resectable Pancreatic Cancer 1Pancreatic Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 104Specimen Handling 76Magnetic Resonance Spectroscopy 66Cisplatin 63Carboplatin 63Biopsy 58Nivolumab 51Cyclophosphamide 47Radiotherapy 45Paclitaxel 43Gemcitabine 37durvalumab 34Radiation 33Rituximab 32Dexamethasone 30olaparib 29Docetaxel 28Doxorubicin 27Etoposide 26atezolizumab 25Ipilimumab 25Lenalidomide 24Bevacizumab 24Taxes 23Pemetrexed 23Vincristine 22Prednisone 22Platinum 22Leucovorin 22Radiotherapy, Intensity-Modulated 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × paricalcitol × 90 days × Clear all
NCT03415854 2026-05-12

NABPLAGEMD

HonorHealth Research Institute

Phase 2 Completed
34 enrolled 11 charts
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

HonorHealth Research Institute

Phase 2 Completed
40 enrolled 22 charts
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡